1.
Quang VT, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, Freynet N, Parinet V, Leclerc M, Maury S, Solary E, Selimoglu-Buet D, Duployez N, Wagner-Ballon O, Sloma I. <i>TET2</i&gt; mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia. haematol [Internet]. 2023Nov.1 [cited 2024Nov.28];108(11):3135-41. Available from: https://haematologica.org/article/view/haematol.2022.282528